Provention Bio (PRVB) Announces Trading Halted Today for FDA Advisory Committee Meeting on Teplizumab

Go back to Provention Bio (PRVB) Announces Trading Halted Today for FDA Advisory Committee Meeting on Teplizumab

Provention Bio Inc. (PRVB) to Resume Trading at 7:10 a.m.

May 28, 2021 7:08 AM EDT

Provention Bio Inc. (NASDAQ: PRVB) to Resume Trading at 7:10 a.m.

... More